YS Biopharma Co Ltd Ordinary Shares YS 深 沪
等待开盘 12-04 09:30:00 美东时间
1.02
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.02
- 总市值 9491.94万
- 52周最高 17.80
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.503
- 委 比 0.00%
- 总股本 9305.82万
- 历史最高 129.30
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.503
- 每 手 1
- 风险率 0.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kyverna Therapeutics shares are trading higher after the company announced interim data from the Phase 2 portion of the registrational KYSA-6 clinical trial of KYV-101 in generalized myasthenia gravis.
Kyverna Therapeutics shares are trading higher after the company announced inte...
10-29 21:04
PROSPERITY BANCSHARES, INC.® REPORTS THIRD QUARTER 2025 EARNINGS
Board approved increase in dividend of 3.45% to $0.60 per share for fourth quarter 2025, representing the 22nd consecutive annual increase, with a compound annual growth rate of 10.7% Net in...
10-29 18:30
YSB Inc. Announces HKD100 Million Share Repurchase Plan
YSB Inc. ( ($HK:9885) ) has provided an announcement. YSB Inc., incorporated in...
10-27 18:08
【行业深度】洞察2025：中国潮玩盲盒行业竞争格局及市场份额（附竞争梯队、市场份额、市场集中度）
转自：前瞻产业研究院 行业主要上市公司：泡泡玛特(09992.HK);名创优品(09896.HK);奥飞娱乐(002292.SZ);高乐股份(002348.S...
10-24 15:00
浮“光”跃金：探寻OCS投资价值与方向
（来源：东北通信科技最前沿） 报告摘要： OCS光交换是一种无需光电/电光（O/E/O）转换，直接实现光信号在光纤端口间切换的技术。OCS原理是直接...
10-23 12:06
Kyverna Therapeutics To Discuss Interim Data From KYSA-6 Phase 2 Clinical Study Evaluating KYV-101 In Generalized Myasthenia Gravis On Oct. 29
Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced it will host a conference call on
10-22 20:03
Karur Vysya Bank to Participate in Asia Non-Deal Roadshow
Karur Vysya Bank Ltd. ( ($IN:KARURVYSYA) ) has issued an announcement. Karur Vy...
10-21 23:12
